C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis

Metabolic outcomes in type 1 diabetes remain suboptimal. Disease modifying therapy to prevent β-cell loss presents an alternative treatment framework but the effect on metabolic outcomes is unclear. We, therefore, aimed to define the relationship between insulin C-peptide as a marker of β-cell funct...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet. Diabetes & endocrinology Jg. 11; H. 12; S. 915
Hauptverfasser:	Taylor, Peter N, Collins, Kimberly S, Lam, Anna, Karpen, Stephen R, Greeno, Brianna, Walker, Frank, Lozano, Alejandro, Atabakhsh, Elnaz, Ahmed, Simi T, Marinac, Marjana, Latres, Esther, Senior, Peter A, Rigby, Mark, Gottlieb, Peter A, Dayan, Colin M
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 01.12.2023
Schlagworte:	Adult C-Peptide - therapeutic use Child Cross-Sectional Studies Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - drug therapy Glycated Hemoglobin Humans Hypoglycemic Agents - therapeutic use Insulin - therapeutic use
ISSN:	2213-8595, 2213-8595
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!